RESEARCH IN ONCOLOGY

Featuring: Ali Shilatifard, PhD, Milan Mrksich, PhD, Lu Wang, PhD
A team of Northwestern Medicine scientists led by Ali Shilatifard, PhD, the Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics, has identified the molecular mechanisms of ASXL1 mutations involved in leukemia pathogenesis, according to a study published in Nature Cancer.

​“This is first inhibitor can benefit the treatment of leukemia patients with ASXL1 mutations,” said Lu Wang, PhD, assistant professor of Biochemistry and Molecular Genetics and lead author of the study.